openPR Logo
Press release

With 9.2% CAGR, Cancer Diagnostics Market Size to Surpass USD 43.7 Billion by the end of 2031

10-09-2023 12:39 PM CET | IT, New Media & Software

Press release from: Global Insight Services

/ PR Agency: Global Insight Services
With 9.2% CAGR, Cancer Diagnostics Market Size to Surpass USD

The Cancer Diagnostics Market has become increasingly vital in the global healthcare landscape as the fight against cancer intensifies. With cancer being a leading cause of mortality worldwide, early and accurate diagnosis is paramount for effective treatment and improved patient outcomes. This market encompasses a wide range of diagnostic tools and techniques, including imaging, molecular diagnostics, and tumor biomarker assays, which play a crucial role in the detection, characterization, and monitoring of various cancer types. One of the primary drivers of the Cancer Diagnostics Market is the growing prevalence of cancer. The incidence of cancer continues to rise due to various factors, including an aging population, lifestyle changes, and environmental factors. As the global burden of cancer increases, so does the demand for advanced diagnostic technologies that can identify cancer at its earliest, most treatable stages. Cancer diagnostics aid in early intervention, which can significantly improve survival rates and reduce the cost of treatment.

Get Access to A Free Sample Copy of Our Latest Report @ https://www.globalinsightservices.com/request-sample/GIS10252

The Cancer Diagnostics Market plays a pivotal role in modern healthcare, offering essential tools and technologies for the early detection, accurate diagnosis, and effective management of various forms of cancer. With cancer's global impact and the increasing emphasis on personalized medicine, the market is experiencing rapid growth driven by advancements in molecular diagnostics, imaging technologies, and liquid biopsies. These innovations enable healthcare professionals to tailor treatment plans to individual patients, improving outcomes and quality of life. As the demand for non-invasive, highly sensitive, and precise diagnostic methods grows, the Cancer Diagnostics Market continues to evolve, reshaping the landscape of oncology care and contributing to the fight against one of the most pressing health challenges of our time.

Read Full Research Report @ https://www.globalinsightservices.com/reports/cancer-diagnostics-market/

Key Trends

The Cancer Diagnostics Market is undergoing transformative trends that are revolutionizing cancer care and diagnosis. Personalized medicine is a significant driver, with a shift towards molecular profiling and genetic testing to tailor treatments based on individual patients' genetic makeup. Liquid biopsies are gaining prominence as a minimally invasive approach for detecting cancer-related genetic alterations, offering real-time insights into disease progression and treatment responses. The integration of artificial intelligence and machine learning in image analysis is enhancing diagnostic accuracy and efficiency in radiology and pathology. Moreover, the rise of companion diagnostics is fostering the development of targeted therapies, optimizing treatment outcomes.

Key Drivers

The Cancer Diagnostics Market is driven by several pivotal factors that are shaping its growth and impact on healthcare. The rising prevalence of cancer globally, coupled with the increasing awareness of early detection's critical role in improving patient outcomes, fuels the demand for advanced diagnostics. Technological advancements, including next-generation sequencing, liquid biopsies, and multiplexed imaging techniques, are propelling the development of more accurate and efficient diagnostic tools. The trend towards personalized medicine, with a focus on targeted therapies, drives the need for precise biomarker identification. Additionally, collaborations between diagnostic companies and pharmaceutical firms are fostering companion diagnostics that aid in therapy selection and monitoring.

Request for Customization @ https://www.globalinsightservices.com/request-customization/GIS10252

Market Segmentation : Cancer Diagnostics Market

Cancer Diagnostics Market By Product : Consumables, Instruments

Cancer Diagnostics Market By Technology : IVD Testing, Imaging, Biopsy Technique

Cancer Diagnostics Market By Application : Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Other Cancers

Cancer Diagnostics Market By End User : Hospitals, Diagnostic, Laboratories

Cancer Diagnostics Market By Region : North America : US, Canada, Mexico, Europe : The UK, Germany, France, Netherlands, Switzerland, Asia-Pacific : China, India, Japan, South Korea, Australia, Singapore, Indonesia, Rest of Asia-Pacific, Rest of the World : Latin America, Middle East, Africa

Buy Now @ https://www.globalinsightservices.com/checkout/single_user/GIS10252

Key Players

GE Healthcare (US)
Abbott Laboratories (US)
Hologic Inc. (US)
Agilent Technologies Inc.(US)
Roche Diagnostics (Switzerland)
FUJIFILM Corporation (Japan)
Danaher Corporation (US)
DiaSorin S.P.A. (Italy)
Myriad Genetics Inc. (US)
Siemens Healthineers AG (Germany)
BD (US)
bioMérieux SA (France)
Bio-Rad Laboratories (US)
Cancer Diagnostics Inc. (US)
Vela Diagnostics (Singapore)
Roche Diagnostics (Switzerland)
AMOY Diagnostics CO. LTD. (China)
Quidel Corporation (US)
Bio SB (US)
Biocartis NV (Belgium)
Exact Science (US)

With Global Insight Services, you receive :

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

New Report Published by Global Insight Services : https://www.globalinsightservices.com/reports/hydrogen-projects-database/

Contact Us :

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 15998
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services :

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release With 9.2% CAGR, Cancer Diagnostics Market Size to Surpass USD 43.7 Billion by the end of 2031 here

News-ID: 3240739 • Views:

More Releases from Global Insight Services

Liver Disease Treatment Market: Expansion Fueled by Increasing Incidence of NAFLD, NASH, and Alcohol-Related Liver Disease | Overall Study Report
Liver Disease Treatment Market: Expansion Fueled by Increasing Incidence of NAFL …
The Liver Disease Treatment Market continues to expand rapidly as global awareness, early diagnosis, and advanced therapeutic approaches reshape patient care. With the market valued at $26.6 billion in 2024 and projected to reach $44.8 billion by 2034 at a steady 5.4% CAGR, demand for effective and accessible therapies is on the rise. The Liver Disease Treatment Market covers pharmaceuticals, biologics, vaccines, diagnostics, and liver transplant services designed to manage
Healthcare Supply Chain BPO Market: Expansion Fueled by Increasing Outsourcing of Procurement, Logistics, and Inventory Management | Overall Study Report
Healthcare Supply Chain BPO Market: Expansion Fueled by Increasing Outsourcing o …
The Healthcare Supply Chain BPO Market is rapidly evolving as healthcare providers worldwide seek smarter, leaner, and more resilient operations. With growing pressure to reduce costs, boost efficiency, and maintain uninterrupted patient care, outsourcing supply chain tasks has become a strategic necessity. The global Healthcare Supply Chain BPO Market is projected to grow from $3.05 billion in 2024 to $4.83 billion by 2034, reflecting a CAGR of 4.7%. This expansion
Robotics Crawler Camera System Market Rise by 2034 | Key Players: Inuktun Services, Deep Trekker, Envirosight
Robotics Crawler Camera System Market Rise by 2034 | Key Players: Inuktun Servic …
Market Overview Robotics Crawler Camera System Market is witnessing a major transformation as industries shift toward advanced inspection technologies that improve safety, accuracy, and operational efficiency. These robotic crawlers, equipped with high-resolution cameras and strong maneuverability, enable real-time inspection across pipelines, sewers, industrial tanks, and hazardous environments where manual inspections pose risks. As automation becomes central to industrial maintenance, the Robotics Crawler Camera System Market continues to gain momentum, supported by
Pet DNA Testing Market Growth to 2034 | Key Players: Wisdom Panel, Embark Veterinary, DNA My Dog
Pet DNA Testing Market Growth to 2034 | Key Players: Wisdom Panel, Embark Veteri …
Market Overview Pet DNA Testing Market is rapidly transforming the way pet owners understand the health, ancestry, and traits of their companion animals. As pets increasingly become family members, owners are demanding deeper insights into their pets' genetic makeup. The Pet DNA Testing Market offers services such as breed identification, disease risk assessments, trait analysis, and ancestry mapping. With advancements in genomics and the expansion of direct-to-consumer testing kits, the Pet

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For